Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Wall Street
Price Targets
Price Targets Summary
Changzhou Qianhong Biopharma Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Changzhou Qianhong Biopharma Co Ltd's stock price target?
Not Available
Changzhou Qianhong Biopharma Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Changzhou Qianhong Biopharma Co Ltd's Revenue forecast?
Projected CAGR
22%
For the last 13 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is 22%.
What is Changzhou Qianhong Biopharma Co Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 13 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's operating income is 8%. The projected CAGR for the next 3 years is 17%.
What is Changzhou Qianhong Biopharma Co Ltd's Net Income forecast?
Projected CAGR
14%
For the last 13 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 14%.
